Why scientists recommend this type of co-enzyme Q10

Our endogenous Q10 production peaks and starts to decline in our early twenties, however, so many choose to take a supplement to compensate for the age-related loss. In a recent report, Austrian scientists specifically...

World-first test for new heart attack drug

The partnership between the University of Birmingham and Acticor Biotech will see patients with heart attacks treated with glenzocimab, a promising new class of drug, for the first time. A potential new drug to improve...

Acesis breaks new ground with novel therapy solution to low testosterone

For the first time in over 70 years, a new testosterone replacement therapy has been unveiled. Dr Vassilios Papadopoulos and Dr Costas Karatzas, co-founders of Acesis BioMed, explain how their ‘first-in-class’ peptide therapeutics could...

AI used to improve cardiovascular risk prediction

AI startup Owkin and Amgen have announced the results of a three-year project using artificial intelligence to more accurately predict cardiovascular risk. This study demonstrates the ability of AI to improve the way that...

Prof. James Leiper, Associate Medical Director at the British Heart Foundation, looks at the...

“There’s a lot of very exciting cardiovascular research going on at the moment which the BHF is heavily investing in – from stem cell therapy and regenerative medicine to identifying genes that could be...

HEART DISEASE RESEARCHERS SET TO WORK WITH THE NOBEL PRIZE-WINNING GENETIC SCISSORS

By Dr Leanne Grech, Research Engagement Officer at the British Heart Foundation We can all agree that 2020 has been a difficult year, but a silver lining was two women winning the Nobel Prize in Chemistry...

Artificial Neural Networks working with Image Guided Therapies to improve heart disease treatment

By Rashed Karim Research Fellow at King’s College London School of Biomedical Engineering and Imaging Sciences It’s exciting to envisage that future treatments for cardiovascular disease will be supported by intelligent systems and devices. At the...

New treatment option 
for ‘wake-up’ stroke patients

Detail revealed in MRI brain scans can help doctors accurately deduce when a stroke begins, according to new research, allowing treatment for many patients who currently cannot receive it. The findings could help to better...

Heart Disease: 
A primary cause of death

Dr Catrin Rutland BSc PGCHE MSc MMedSci PhD SFHEA FAS Heart disease is one of the primary causes of death throughout the world in both humans and animals. Research at The School of Veterinary Medicine...

Patients who have had an irregular heart beat can’t ever be considered ‘cured’, say...

Patients with an abnormal heart rhythm that can leave them at a higher risk of suffering from stroke still need treatment even after their heart rhythm seems to have returned to normal, say researchers...

New link between gut microbiome and artery hardening discovered

The gut microbiome is under increasing scrutiny in medical research as it is known to affect many different aspects of our health, including our metabolism and auto-immune system. A lack of diversity or range...

Combatting cardiovascular disease today

Cardiovascular disease remains the most common cause of death in the UK and across the world, so in this issue of BioScience Today, Ellen Rossiter speaks to Dr Vijay Kunadian, Senior Lecturer and Honorary...

Six Years of Exercise or Lack of It – May Be Enough to Change...

By analyzing reported physical activity levels over time in more than 11,000 American adults, Johns Hopkins Medicine researchers conclude that increasing physical activity to recommended levels over as few as six years in middle...

Ulster University leads on €8.2M cross border collaborative research centre

The EU funded cross border centre of research excellence in cardiovascular medicine will transform cardiac care in the region by developing new models of care, smart wearable technologies and improved patient monitoring systems. The Eastern...

Breaking through cardiovascular disease

Professor Metin Avkiran, Associate Medical Director at the British Heart Foundation (BHF) explains the work they are doing to find the next breakthrough treatment for cardiovascular disease. Since the BHF was formed over 50 years...